Literature DB >> 31034208

Dynamics of Zika Virus Capsid Protein in Solution: The Properties and Exposure of the Hydrophobic Cleft Are Controlled by the α-Helix 1 Sequence.

Maria A Morando1,2,3, Glauce M Barbosa1, Christine Cruz-Oliveira1,2, Andrea T Da Poian1, Fabio C L Almeida1,2.   

Abstract

Zika virus (ZIKV) became an important public health concern because infection was correlated to the development of microcephaly and other neurological disorders. Although the structure of the virion has been determined by cryo-electron microscopy, information about the nucleocapsid is lacking. We used nuclear magnetic resonance to determine the solution structure and dynamics of full length ZIKV capsid protein (ZIKVC). Although most of the protein is structured as described for the capsid proteins of Dengue and West Nile viruses and for truncated ZIKVC (residues 23-98), here we show important differences in the α-helix 1 and N-terminal intrinsically disordered region (IDR). We distinguished two dynamical regions in the ZIKVC IDR, a highly flexible N-terminal end and a transitional disordered region, indicating that it contains ordered segments rather than being completely flexible. The unique size and orientation of α-helix 1 partially occlude the protein hydrophobic cleft. Measurements of the dynamics of α-helix 1, surface exposure, and thermal susceptibility of each backbone amide 1H in protein structure revealed the occlusion of the hydrophobic cleft by α1/α1' and supported α-helix 1 positional uncertainty. On the basis of the findings described here, we propose that the dynamics of ZIKVC structural elements responds to a structure-driven regulation of interaction of the protein with intracellular hydrophobic interfaces, which would have an impact on the switches that are necessary for nucleocapsid assembly. Subtle differences in the sequence of α-helix 1 have an impact on its size and orientation and on the degree of exposure of the hydrophobic cleft, suggesting that α-helix 1 is a hot spot for evolutionary adaptation of the capsid proteins of flaviviruses.

Entities:  

Year:  2019        PMID: 31034208     DOI: 10.1021/acs.biochem.9b00194

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Biophysical and Dynamic Characterization of Fine-Tuned Binding of the Human Respiratory Syncytial Virus M2-1 Core Domain to Long RNAs.

Authors:  Icaro P Caruso; Giovana C Guimarães; Vitor B Machado; Marcelo A Fossey; Dieter Willbold; Fabio C L Almeida; Fátima P Souza
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

2.  Structural and Functional Properties of the Capsid Protein of Dengue and Related Flavivirus.

Authors:  André F Faustino; Ana S Martins; Nina Karguth; Vanessa Artilheiro; Francisco J Enguita; Joana C Ricardo; Nuno C Santos; Ivo C Martins
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

3.  Searching for drug leads targeted to the hydrophobic cleft of dengue virus capsid protein.

Authors:  Liliane O Ortlieb; Ícaro P Caruso; Nathane C Mebus-Antunes; Andrea T Da Poian; Elaine da C Petronilho; José Daniel Figueroa-Villar; Claudia J Nascimento; Fabio C L Almeida
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

Review 4.  Structure and function of capsid protein in flavivirus infection and its applications in the development of vaccines and therapeutics.

Authors:  Xingcui Zhang; Yanting Zhang; Renyong Jia; Mingshu Wang; Zhongqiong Yin; Anchun Cheng
Journal:  Vet Res       Date:  2021-06-30       Impact factor: 3.683

5.  The dynamics of free and phosphopeptide-bound Grb2-SH2 reveals two dynamically independent subdomains and an encounter complex with fuzzy interactions.

Authors:  Karoline Sanches; Icaro P Caruso; Fabio C L Almeida; Fernando A Melo
Journal:  Sci Rep       Date:  2020-08-03       Impact factor: 4.379

Review 6.  The role of capsid in the flaviviral life cycle and perspectives for vaccine development.

Authors:  Yu He; Mingshu Wang; Shun Chen; Anchun Cheng
Journal:  Vaccine       Date:  2020-09-17       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.